CV Sciences Eagerly Anticipating FDA Rulemaking On CBD In Dietary Supplements
Executive Summary
Duffy MacKay, senior VP of scientific and regulatory affairs at CV Sciences, offers his predictions regarding the FDA’s likely course in regulating CBD’s use in dietary supplements – action that is sorely needed as the market continues to crowd with CBD products “with who-knows-what in them.”
You may also be interested in...
HempFusion Publishes CBD GRAS As Food For Thought On NDI Notification It's Ready To Serve
Denver firm recently announced self-affirmed GRAS for proprietary hemp-derived CBD extract. “I have access now to food, beverage and I can add to a dietary supplement my extract as a food additive ingredient,” says CEO Jason Mitchell. While GRAS is a US regulatory pathway for food, currently none is available for lawful use of hemp-derived ingredients in supplements.
CBD Class-Action Litigants Watching For Retroactive Effects In US FDA’s Awaited Rulemaking
Even in the “highly unlikely event” that the FDA does make CBD supplements legal, it will not do so retroactively, according to plaintiffs against CV Sciences in California’s Central District. However, the federal court, which also is hearing a similar case against competitor Charlotte’s Web, is not convinced.
CBD Sheet Mask Brand Fails To Sway NAD: We Only Claimed It ‘May’ Have Benefits
The National Advertising Division has notified the US Federal Trade Commission of claims seen at Bloomingdales.com for one of Mask, LLC’s CBD-infused sheet masks, including the product’s name, which implies unsupported acne treatment benefits, according to the NAD.